 A retrospective comparison of WT1 and BCR-ABL1 expression was performed in 40 imatinib-treated chronic myeloid leukaemia patients.     ///    In two patients WT1 expression was increasing despite very low BCR-ABL1 levels.     ///    The overall correlation of WT1 and BCR-ABL1 was low. 